Aprea Therapeutics
Price & Volume
Stats
See more52W Range | $2.15-$8.84 |
Market Cap | $15.4M |
Shares Short | 44,890 |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | 11% |
Gross Profit (12 Mos) | -$7.7M |
Diluted EPS | -$2.80 |
News
See moreYahoo Finance • last year
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
Yahoo Finance • last year
Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways
About
CEO | Dr. Oren Gilad Ph.D. |
CFO | Mr. John P. Hamill CPA |
Address | 3805 Old Easton Road, Doylestown, PA, United States, 18902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
